Cargando…

An Overview of Our Current Understanding of Diabetic Macular Ischemia (DMI)

Diabetic macular ischemia (DMI) is a troublesome complication of diabetes mellitus. The pathogenesis, progression, consequences, and treatment options for this disease are still poorly understood. However, it is believed that this complication is associated with several risk factors like poor glycem...

Descripción completa

Detalles Bibliográficos
Autor principal: Usman, Muhammad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6166915/
https://www.ncbi.nlm.nih.gov/pubmed/30280060
http://dx.doi.org/10.7759/cureus.3064
_version_ 1783360108128894976
author Usman, Muhammad
author_facet Usman, Muhammad
author_sort Usman, Muhammad
collection PubMed
description Diabetic macular ischemia (DMI) is a troublesome complication of diabetes mellitus. The pathogenesis, progression, consequences, and treatment options for this disease are still poorly understood. However, it is believed that this complication is associated with several risk factors like poor glycemic control and high blood pressure. Two factors have been identified in the pathogenesis of the disease that play pivotal roles in disease development and progression. One of these factors includes extensive damage to the microvasculature of the retina. This includes narrowing of the vascular lumen and extensive damage to the endothelial cells, pericytes and the extracellular matrix. The second factor includes extensive damage to the neurosensory layer of the retina. DMI is always associated with other complications of diabetic retinopathy like retinal edema, so it is very difficult to find an isolated case of DMI. Moreover, the condition is also very rare making it very difficult to study and diagnose. However, a number of diagnostic tests like optical coherence tomography (OCT), fluorescence angiography (FA), and perimetry can be used as tools for the early detection of DMI. Since this disease damages the retina, loss of vision is an inevitable consequence that can progressively worsen over time. Also, DMI has been implicated as a risk factor for retinal edema and progressive diabetic retinopathy. Until now, no defined treatment protocol has been devised. The only available treatments focus on the management of risk factors (hyperglycemia and hypertension). Still, many aspects of DMI remain poorly studied and understood. This review paper aims to add to our current understanding of diabetic macular ischemia (DMI).
format Online
Article
Text
id pubmed-6166915
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-61669152018-10-02 An Overview of Our Current Understanding of Diabetic Macular Ischemia (DMI) Usman, Muhammad Cureus Endocrinology/Diabetes/Metabolism Diabetic macular ischemia (DMI) is a troublesome complication of diabetes mellitus. The pathogenesis, progression, consequences, and treatment options for this disease are still poorly understood. However, it is believed that this complication is associated with several risk factors like poor glycemic control and high blood pressure. Two factors have been identified in the pathogenesis of the disease that play pivotal roles in disease development and progression. One of these factors includes extensive damage to the microvasculature of the retina. This includes narrowing of the vascular lumen and extensive damage to the endothelial cells, pericytes and the extracellular matrix. The second factor includes extensive damage to the neurosensory layer of the retina. DMI is always associated with other complications of diabetic retinopathy like retinal edema, so it is very difficult to find an isolated case of DMI. Moreover, the condition is also very rare making it very difficult to study and diagnose. However, a number of diagnostic tests like optical coherence tomography (OCT), fluorescence angiography (FA), and perimetry can be used as tools for the early detection of DMI. Since this disease damages the retina, loss of vision is an inevitable consequence that can progressively worsen over time. Also, DMI has been implicated as a risk factor for retinal edema and progressive diabetic retinopathy. Until now, no defined treatment protocol has been devised. The only available treatments focus on the management of risk factors (hyperglycemia and hypertension). Still, many aspects of DMI remain poorly studied and understood. This review paper aims to add to our current understanding of diabetic macular ischemia (DMI). Cureus 2018-07-30 /pmc/articles/PMC6166915/ /pubmed/30280060 http://dx.doi.org/10.7759/cureus.3064 Text en Copyright © 2018, Usman et al. http://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Endocrinology/Diabetes/Metabolism
Usman, Muhammad
An Overview of Our Current Understanding of Diabetic Macular Ischemia (DMI)
title An Overview of Our Current Understanding of Diabetic Macular Ischemia (DMI)
title_full An Overview of Our Current Understanding of Diabetic Macular Ischemia (DMI)
title_fullStr An Overview of Our Current Understanding of Diabetic Macular Ischemia (DMI)
title_full_unstemmed An Overview of Our Current Understanding of Diabetic Macular Ischemia (DMI)
title_short An Overview of Our Current Understanding of Diabetic Macular Ischemia (DMI)
title_sort overview of our current understanding of diabetic macular ischemia (dmi)
topic Endocrinology/Diabetes/Metabolism
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6166915/
https://www.ncbi.nlm.nih.gov/pubmed/30280060
http://dx.doi.org/10.7759/cureus.3064
work_keys_str_mv AT usmanmuhammad anoverviewofourcurrentunderstandingofdiabeticmacularischemiadmi
AT usmanmuhammad overviewofourcurrentunderstandingofdiabeticmacularischemiadmi